According to these previous findings, we believed that identification of factors influencing activation and expression of AXL and members of the ErbB family may be useful for improving the efficacy of EGFR-TKIs and may thereby benefit patients with EGFRM NSCLC. Here, AXL is linked to non-small cell lung carcinoma.